0.612
price up icon0.29%   0.0018
after-market 시간 외 거래: .64 0.028 +4.58%
loading
전일 마감가:
$0.6102
열려 있는:
$0.63
하루 거래량:
366.95K
Relative Volume:
1.69
시가총액:
$35.81M
수익:
-
순이익/손실:
$-17.78M
주가수익비율:
-1.1143
EPS:
-0.5492
순현금흐름:
$-10.52M
1주 성능:
-14.04%
1개월 성능:
-22.38%
6개월 성능:
-71.13%
1년 성능:
-85.53%
1일 변동 폭
Value
$0.6016
$0.65
1주일 범위
Value
$0.594
$0.74
52주 변동 폭
Value
$0.594
$5.62

Fibrobiologics Inc Stock (FBLG) Company Profile

Name
명칭
Fibrobiologics Inc
Name
전화
281-671-5150
Name
주소
455 E. MEDICAL CENTER BLVD, HOUSTON
Name
직원
13
Name
트위터
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
FBLG's Discussions on Twitter

FBLG을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
FBLG
Fibrobiologics Inc
0.612 35.81M 0 -17.78M -10.52M -0.5492
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
459.62 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.36 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
331.91 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
543.48 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.49 28.51B 3.81B -644.79M -669.77M -6.24

Fibrobiologics Inc Stock (FBLG) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-12-12 개시 Rodman & Renshaw Buy
2024-10-30 개시 H.C. Wainwright Buy
2024-09-24 개시 Maxim Group Buy

Fibrobiologics Inc 주식(FBLG)의 최신 뉴스

pulisher
Jun 16, 2025

Fibrobiologics closes third $5 mln tranche of $25 mln financing - MarketScreener

Jun 16, 2025
pulisher
Jun 16, 2025

FibroBiologics Closes Third $5 Million Tranche of $25 Million Financing - GlobeNewswire

Jun 16, 2025
pulisher
Jun 16, 2025

FibroBiologics Raises $25M to Launch Breakthrough Diabetic Foot Ulcer Treatment Trial - Stock Titan

Jun 16, 2025
pulisher
Jun 16, 2025

FibroBiologics to Present Company Update and Research Advances at BIO International Convention 2025 - Nasdaq

Jun 16, 2025
pulisher
Jun 16, 2025

FibroBiologics to Present at the BIO International Convention 2025 - GlobeNewswire

Jun 16, 2025
pulisher
Jun 16, 2025

Clinical Trial Alert: FibroBiologics Unveils Groundbreaking Fibroblast Treatment for Chronic Disease at BIO 2025 - Stock Titan

Jun 16, 2025
pulisher
Jun 16, 2025

FibroBiologics, Inc. (NASDAQ:FBLG) Receives Consensus Rating of “Buy” from Brokerages - Defense World

Jun 16, 2025
pulisher
Jun 10, 2025

FibroBiologics names new CFO after going public last year - The Business Journals

Jun 10, 2025
pulisher
Jun 09, 2025

FibroBiologics appoints new CFO amid clinical trials By Investing.com - Investing.com South Africa

Jun 09, 2025
pulisher
Jun 09, 2025

FibroBiologics, Inc. Appoints Jason D. Davis as Chief Financial Officer, Effective June 9, 2025 - MarketScreener

Jun 09, 2025
pulisher
Jun 09, 2025

FibroBiologics appoints Jason Davis as CFO - TipRanks

Jun 09, 2025
pulisher
Jun 09, 2025

FibroBiologics Appoints Jason Davis As CFO - Nasdaq

Jun 09, 2025
pulisher
Jun 09, 2025

FibroBiologics appoints new CFO amid clinical trials - Investing.com Australia

Jun 09, 2025
pulisher
Jun 09, 2025

FibroBiologics, Inc. Appoints Jason D. Davis as Chief Financial Officer to Drive Growth and Clinical Development - Nasdaq

Jun 09, 2025
pulisher
Jun 09, 2025

FibroBiologics Appoints Jason D. Davis, CPA, as Chief Financial Officer - GlobeNewswire

Jun 09, 2025
pulisher
Jun 09, 2025

FibroBiologics Taps Former Virax IPO Leader as CFO Ahead of Critical Clinical Trials - Stock Titan

Jun 09, 2025
pulisher
Jun 08, 2025

Jane Street Group LLC Acquires 49,222 Shares of FibroBiologics, Inc. (NASDAQ:FBLG) - Defense World

Jun 08, 2025
pulisher
May 27, 2025

Top Executive Makes Bold Move with Major Stock Purchase in FibroBiologics! - TipRanks

May 27, 2025
pulisher
May 25, 2025

FibroBiologics, Inc. (NASDAQ:FBLG) Receives $13.00 Consensus PT from Analysts - Defense World

May 25, 2025
pulisher
May 23, 2025

FBLG: Poster Presentation Shows Potential for Fibroblast Therapy in Psoriasis - Research Tree

May 23, 2025
pulisher
May 22, 2025

FBLG: Poster Presentation Shows Potential for Fibroblast Therapy in Psoriasis… - Zacks Small Cap Research

May 22, 2025
pulisher
May 17, 2025

FibroBiologics Presents at the Society for Investigative Dermatology Annual Meeting - GlobeNewswire

May 17, 2025
pulisher
May 17, 2025

D. Boral Capital Reiterates Buy Rating for FibroBiologics (NASDAQ:FBLG) - Defense World

May 17, 2025
pulisher
May 16, 2025

FibroBiologics Presents Research on Human Dermal Fibroblast Spheroids for Psoriasis Therapy at SID Annual Meeting - Nasdaq

May 16, 2025
pulisher
May 16, 2025

Revolutionary Fibroblast Treatment Shows Promise for Long-lasting Psoriasis Relief, New Data Reveals - Stock Titan

May 16, 2025
pulisher
May 15, 2025

Raymond James Financial Inc. Takes $37,000 Position in FibroBiologics, Inc. (NASDAQ:FBLG) - Defense World

May 15, 2025
pulisher
May 14, 2025

FibroBiologics Reports First Quarter 2025 Financial Results And Provides Corporate Update - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

FibroBiologics, Inc. Reports First Quarter 2025 Financial Results and Operational Milestones - Nasdaq

May 14, 2025
pulisher
May 14, 2025

FibroBiologics Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire

May 14, 2025
pulisher
May 14, 2025

FibroBiologics Earnings: Net Loss Drops 41%, Clinical Trial Launch Set for Breakthrough Wound Treatment - Stock Titan

May 14, 2025
pulisher
May 14, 2025

FibroBiologics, Inc. SEC 10-Q Report - TradingView

May 14, 2025
pulisher
May 11, 2025

FibroBiologics (FBLG) Projected to Post Earnings on Tuesday - Defense World

May 11, 2025
pulisher
May 06, 2025

CytoDyn Appoints Biotech Veteran Robert E. Hoffman as Chief Financial Officer - CytoDyn Inc.

May 06, 2025
pulisher
May 06, 2025

Biotech Veteran Robert Hoffman Joins CytoDyn as CFO: Key Strategic Hire for Leronlimab Developer - Stock Titan

May 06, 2025
pulisher
May 05, 2025

Fibrobiologics Inc Says On May 2, Robert E. Hoffman Resigns As Interim CFO Effective May 14, 2025SEC Filing - marketscreener.com

May 05, 2025
pulisher
May 05, 2025

FibroBiologics CFO Robert Hoffman Resigns - TipRanks

May 05, 2025
pulisher
Apr 29, 2025

FibroBiologics Presents at the ThymUS 2025 Meeting - GlobeNewswire

Apr 29, 2025
pulisher
Apr 29, 2025

FibroBiologics Research Scientist Presents Innovative Thymus Organoid Development at ThymUS 2025 Meeting - Nasdaq

Apr 29, 2025
pulisher
Apr 29, 2025

Revolutionary Thymus Organoid Breakthrough: FibroBiologics Reveals New T-Cell Generation Method - Stock Titan

Apr 29, 2025
pulisher
Apr 26, 2025

FibroBiologics, Inc. (NASDAQ:FBLG) Shares Acquired by Cerity Partners LLC - Defense World

Apr 26, 2025
pulisher
Apr 22, 2025

FibroBiologics Inc Inc. (FBLG) Price Performance: A Technical Analysis Perspective - investchronicle.com

Apr 22, 2025
pulisher
Apr 15, 2025

O Shaughnessy Asset Management LLC Acquires New Position in FibroBiologics, Inc. (NASDAQ:FBLG) - Defense World

Apr 15, 2025
pulisher
Apr 14, 2025

Raymond James Financial Inc. Invests $37,000 in FibroBiologics, Inc. (NASDAQ:FBLG) - Defense World

Apr 14, 2025
pulisher
Apr 12, 2025

FibroBiologics’ (FBLG) Buy Rating Reiterated at D. Boral Capital - Defense World

Apr 12, 2025
pulisher
Apr 11, 2025

FibroBiologics to Present at The Cell & Gene Meeting on the Mediterranean - GlobeNewswire

Apr 11, 2025
pulisher
Apr 11, 2025

Revolutionary Cell Therapy: FibroBiologics Unveils Multi-Disease Treatment Platform in Rome - Stock Titan

Apr 11, 2025
pulisher
Apr 10, 2025

Houston Biotechnology Company Brings Manufacturing Ops Home With New Facility - Bisnow

Apr 10, 2025
pulisher
Apr 09, 2025

Fibrobiologics stock plunges to 52-week low at $0.8 amid market challenges By Investing.com - Investing.com South Africa

Apr 09, 2025
pulisher
Apr 09, 2025

Fibrobiologics stock plunges to 52-week low at $0.8 amid market challenges - Investing.com India

Apr 09, 2025
pulisher
Apr 09, 2025

FibroBiologics opens cell therapy manufacturing space ahead of clinical trials - The Business Journals

Apr 09, 2025
pulisher
Apr 09, 2025

OTC Markets Hosts Virtual Investor Presentation with Pete O'Heeron, CEO & Chairman of FibroBiologics, Inc., with David Bautz, PhD, Senior Analyst at Zacks SCR - Yahoo Finance

Apr 09, 2025

Fibrobiologics Inc (FBLG) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Fibrobiologics Inc 주식 (FBLG) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
O'HEERON PETE
Chief Executive Officer
Aug 12 '24
Buy
1.91
8,500
16,269
6,056,647
Khoja Hamid
Chief Scientific Officer
Aug 12 '24
Buy
1.90
10,000
19,000
11,250
$20.30
price down icon 0.68%
$36.37
price up icon 0.50%
$24.55
price up icon 8.53%
$97.80
price down icon 0.45%
$110.00
price up icon 1.61%
biotechnology ONC
$245.49
price up icon 0.48%
자본화:     |  볼륨(24시간):